Back to Search
Start Over
Creation of an adequate animal model of hyperuricemia (acute and chronic hyperuricemia); study of its reversibility and its maintenance
- Source :
- Life sciences. 268
- Publication Year :
- 2020
-
Abstract
- Aim Hyperuricemia is defined by the European Rheumatology Society as a uric acid level greater than 6 mg/dl (60 mg/l or 360 μmol/l). Our goal was to evaluate the hypouricemic effect of nettle. For this reason, we have first of all try to create an hyperuricemic animal model which is very suitable because at the level of literature there is not an exact model, there are many models and our objective is to set an adequate model. Materials and methods An attempt has been made to test acute and chronic hyperuricemia by varying the duration and method of induction of potassium oxonate. Similarly, attempts have been made to induce chronic hyperuricemia through an animal and vegetable diet. The reversibility of hyperuricemia was tested with a maintenance protocol. Key findings For the creation of the hyperuricemia model, it has been shown that acute hyperuricemia cannot be induced by short administration of potassium oxonate and persistent chronic hyperuricemia can be induced only after daily administration of oxonate of potassium by intraperitoneal injection for 15 days. Indeed, hyperuricemia was reversible after stopping the administration of potassium oxonate. The high-purine diet is also capable of inducing chronic hyperuricemia but to a less extent. Significance After creating an adequate model of hyperuricemia while setting the dose of potassium oxonate, route of administration and duration. A maintenance protocol was followed which subsequently made it possible to deduce that the daily administration of potassium oxonate must be continued to maintain the hyperuricemia.
- Subjects :
- musculoskeletal diseases
0301 basic medicine
Male
congenital, hereditary, and neonatal diseases and abnormalities
Potassium oxonate
Hyperuricemia
Pharmacology
urologic and male genital diseases
Kidney
030226 pharmacology & pharmacy
General Biochemistry, Genetics and Molecular Biology
Antioxidants
03 medical and health sciences
Route of administration
chemistry.chemical_compound
0302 clinical medicine
Animal model
Medicine
Animals
Urea
General Pharmacology, Toxicology and Pharmaceutics
Rats, Wistar
Exact model
business.industry
nutritional and metabolic diseases
General Medicine
medicine.disease
Uric Acid
Disease Models, Animal
Oxonic Acid
030104 developmental biology
chemistry
Liver
Creatinine
Chronic Disease
Uric acid
Lipid Peroxidation
business
Biomarkers
Subjects
Details
- ISSN :
- 18790631
- Volume :
- 268
- Database :
- OpenAIRE
- Journal :
- Life sciences
- Accession number :
- edsair.doi.dedup.....cc9c8b34fc797f654ef2307508ee861c